In gnomAD, the MAF of ESR1 variants showing association with having a TP53 mutation in our study are lowest in individuals of European, Latin American, and South Asian ancestry and are higher in individuals of African and EAS which may explain in part the higher proportion of breast tumors in these populations with TP53 mutations in these populations. This evidence concerns the gene TP53 and breast neoplasm.